title: [Naftidrofuryl in patients with prosthetic femoral-popliteal bypass].
authors.forename: T
authors.initials: T
authors.lastname: Noppeney
authors.forename: P
authors.initials: P
authors.lastname: Kasprzak
authors.forename: D
authors.initials: D
authors.lastname: Raithel
authors.forename: H
authors.initials: H
authors.lastname: Hirche
mesh_terms: D000328:Adult; D000368:Aged; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D001807:Blood Vessel Prosthesis; D002986:Clinical Trials as Topic; D005260:Female; D005263:Femoral Artery / Q000601:surgery*; D005663:Furans / Q000627:therapeutic use*; D006083:Graft Occlusion, Vascular / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009257:Nafronyl / Q000009:adverse effects / Q000627:therapeutic use*; D011138:Polytetrafluoroethylene; D011150:Popliteal Artery / Q000601:surgery*; D011897:Random Allocation
chemical_list: D005663:Furans; D009257:Nafronyl; D011138:Polytetrafluoroethylene; D001241:Aspirin
vernacular_title: Uber den Einsatz von Naftidrofuryl bei Patienten mit femoro-poplitealem Kunststoff-Bypass.